Cargando…
Vasculotide reduces pulmonary hyperpermeability in experimental pneumococcal pneumonia
BACKGROUND: Community-acquired pneumonia (CAP) is a significant cause of morbidity and mortality worldwide. Despite effective antimicrobial therapy, CAP can induce pulmonary endothelial hyperpermeability resulting in life-threatening lung failure due to an exaggerated host-pathogen interaction. Trea...
Autores principales: | Gutbier, Birgitt, Jiang, Xiaohui, Dietert, Kristina, Ehrler, Carolin, Lienau, Jasmin, Van Slyke, Paul, Kim, Harold, Hoang, Van C., Maynes, Jason T., Dumont, Daniel J., Gruber, Achim D., Weissmann, Norbert, Mitchell, Timothy J., Suttorp, Norbert, Witzenrath, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683375/ https://www.ncbi.nlm.nih.gov/pubmed/29132435 http://dx.doi.org/10.1186/s13054-017-1851-6 |
Ejemplares similares
-
Adjunctive therapy with the Tie2 agonist Vasculotide reduces pulmonary permeability in Streptococcus pneumoniae infected and mechanically ventilated mice
por: Lask, Aina, et al.
Publicado: (2022) -
Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia
por: Berger, Sarah, et al.
Publicado: (2018) -
Vasculotide, an Angiopoietin-1 mimetic, ameliorates several features of experimental atopic dermatitis-like disease
por: Bourdeau, Annie, et al.
Publicado: (2016) -
Therapeutic strategies in pneumonia: going beyond antibiotics
por: Müller-Redetzky, Holger, et al.
Publicado: (2015) -
Krueppel-Like Factor 4 Expression in Phagocytes Regulates Early Inflammatory Response and Disease Severity in Pneumococcal Pneumonia
por: Herta, Toni, et al.
Publicado: (2021)